Exozymes Inc.EXOZ

NasdaqHealthcareBiological Products, (No Diagnostic Substances)
Price (close)
$6.33
Market cap
$58.8M
P/E
—
Revenue (TTM)
—
Net income
-$10.2M
Dividend yield
—
1-year total return
-56.5%
Net margin
—
Revenue growth
—
Debt / equity
—

What Exozymes Inc. does.

are ubiquitous in modern life - they form the basis of medicines, fuels, plastics, food, and colors, among many other applications that

chemicals from nature via traditional extraction methods is often inefficient and often requires large amounts of biological material

to extract the necessary amounts of the desired chemical compounds. So, despite maybe being sustainable, it is not enough to supply the

Revenue and profit, by fiscal year.

Fiscal year2022202320242025
Revenue—$70,069——
Net income—-$2.0M-$5.9M-$9.2M
Free cash flow—-$1.5M-$8.9M-$6.7M

More on EXOZ.

Figures from Exozymes Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.